Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC

Clinical trial NCT05446467 · RECRUITING

Trial details

NCT number: NCT05446467
Sponsor: Zhejiang Provincial People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2022-09-01
Primary completion: 2026-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.